Mobile

A four-week trial evaluating the efficacy, safety and tolerance of GRT6005, a new centrally acting analgesic, in patients with pain due to diabetic nerve damages

Update Il y a 4 ans
Reference: EUCTR2010-022557-42

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To evaluate the analgesic efficacy of fixed doses of 25 µg, 75 µg, and 200 µg GRT6005 once daily compared to placebo in subjects with moderate to severe pain due to diabetic polyneuropathy.

Inclusion criteria

  • Pain due to diabetic polyneuropathy

Links